RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small

Xiujie Xie1, H Patrick Macknight1, Amy L Lu1

  • 1Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.

PubMed

Insights

A novel long non-coding RNA, CyKILR, is overexpressed in non-small cell lung cancer (NSCLC) and exhibits distinct tumor-suppressive (CyKILRa) and oncogenic (CyKILRb) functions, regulated by CDKN2A and STK11 tumor suppressors.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Non-coding RNA Research

Background:

  • The CDKN2A gene, encoding tumor suppressors p16(INK4A) and p14(ARF), is frequently inactivated in non-small cell lung cancer (NSCLC).
  • Understanding the role of non-coding RNAs in cancer development is crucial for identifying new therapeutic targets.

Purpose of the Study:

  • To characterize a novel long non-coding RNA (lncRNA) overexpressed in NSCLC cells with active CDKN2A.
  • To elucidate the functional roles of different splice variants of this lncRNA in tumorigenesis.

Main Methods:

  • Identification and naming of the lncRNA (CyKILR) and its splice variants (CyKILRa, CyKILRb).
  • Analysis of CyKILR regulation by CDKN2A and STK11 tumor suppressor genes.
  • Subcellular localization studies (nucleus for CyKILRa, cytoplasm for CyKILRb).
  • Functional assays following knockdown of CyKILR variants (proliferation, migration, survival, tumor incidence).
  • Transcriptomics to determine pathway involvement (apoptosis, cell cycle, miRNA regulation).

Main Results:

  • CyKILR is overexpressed in NSCLC with wild-type CDKN2A and correlates with wild-type STK11.
  • CDKN2A and STK11 cooperatively regulate CyKILR splicing, specifically exon 3 inclusion.
  • CyKILRa (nuclear) knockdown enhanced proliferation, migration, survival, and tumor incidence.
  • CyKILRb (cytoplasmic) knockdown reduced proliferation, migration, survival, and tumor incidence.
  • CyKILRa promoted apoptosis and suppressed cell-cycle pathways; CyKILRb inhibited tumor suppressor miRNAs.

Conclusions:

  • CyKILR exhibits dual roles in NSCLC, with CyKILRa acting as a tumor suppressor and CyKILRb as an oncogene.
  • The expression and function of CyKILR variants are intricately linked to CDKN2A and STK11 status.
  • This study reveals novel insights into lncRNA involvement in cancer cell signaling and tumorigenesis.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
13.1K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.6K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K